30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Furiex Pharmaceuticals LLC (FURX)

Track

Stock chart
Ticker: FURX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
COVINGTON PAUL S
Senior VP-Clinical Operations
1 sale — total 1,079,516 USD
Sale 24 Jun 2014
Value US$2,849,836.25 | Price 110.09 | Shares 65,603
Sale 24 Jun 2014
Value US$1,920,753.09 | Price 225.25 | Shares 74,525
Sale 18 Jun 2014
Value US$4,756,890.01 | Price 104.11 | Shares 45,691
Sale 17 Jun 2014
Value US$840,840.00 | Price 105.00 | Shares 8,008
Sale 16 Jun 2014
Value US$390,470.85 | Price 105.05 | Shares 3,717
Sale 16 Jun 2014
Value US$2,730,260.00 | Price 105.01 | Shares 26,000
Sale 16 Jun 2014
Value US$3,457,440.00 | Price 105.00 | Shares 32,928
Sale 16 Jun 2014
Value US$399,420.00 | Price 105.00 | Shares 3,804
Sale 13 Jun 2014
Value US$336,519.00 | Price 104.25 | Shares 3,228
Planned sale 4 Feb 2014
Value US$2,568,153.50 | Price 118.25 | Shares 21,718
Planned sale 4 Feb 2014
Value US$10,703,067.00 | Price 114.60 | Shares 93,395
Sale 10 Sep 2013
Value US$1,226,700.00 | Price 40.89 | Shares 30,000
Sale 9 Aug 2013
Value US$298,050.00 | Price 39.74 | Shares 7,500
Planned sale 19 Jul 2013
Value US$423,240.00 | Price 40.00 | Shares 10,581
Sale 28 Jun 2013
Value US$13,101.55 | Price 34.03 | Shares 385
Sale 12 Mar 2013
Value US$39,610.83 | Price 40.71 | Shares 973
Sale 12 Mar 2013
Value US$173,506.02 | Price 40.71 | Shares 4,262
Sale 11 Mar 2013
Value US$224,519.46 | Price 41.74 | Shares 5,379
Sale 11 Mar 2013
Value US$983,603.10 | Price 41.74 | Shares 23,565
Buy 15 Aug 2012
Value US$17,746.00 | Price 18.68 | Shares 950
Buy 14 Aug 2012
Value US$927.50 | Price 18.55 | Shares 50
Buy 14 Jun 2012
Value US$649,892.32 | Price 19.04 | Shares 34,133
Buy 13 Jun 2012
Value US$810,057.69 | Price 18.33 | Shares 44,193
Buy 1 Jun 2012
Value US$992,290.68 | Price 19.72 | Shares 50,319
Buy 31 May 2012
Value US$1,405,704.50 | Price 20.06 | Shares 70,075
Buy 30 May 2012
Value US$1,913,898.27 | Price 19.87 | Shares 96,321
Buy 29 May 2012
Value US$1,445,722.76 | Price 19.96 | Shares 72,431
Buy 25 May 2012
Value US$26,826.30 | Price 18.45 | Shares 1,454
Buy 24 May 2012
Value US$485,730.00 | Price 17.99 | Shares 27,000
Buy 23 May 2012
Value US$354,600.00 | Price 17.73 | Shares 20,000
Buy 22 May 2012
Value US$592,550.00 | Price 16.93 | Shares 35,000
Buy 21 May 2012
Value US$38,760.00 | Price 16.15 | Shares 2,400
Buy 18 May 2012
Value US$382,000.00 | Price 15.28 | Shares 25,000
Buy 17 May 2012
Value US$29,600.00 | Price 14.80 | Shares 2,000
Buy 15 Mar 2012
Value US$169,808.82 | Price 23.91 | Shares 7,102
Buy 14 Mar 2012
Value US$539,433.75 | Price 23.75 | Shares 22,713
Buy 13 Mar 2012
Value US$529,829.30 | Price 23.45 | Shares 22,594
Buy 12 Mar 2012
Value US$507,144.19 | Price 22.69 | Shares 22,351
Buy 9 Mar 2012
Value US$344,203.83 | Price 22.59 | Shares 15,237
Buy 8 Mar 2012
Value US$335,863.28 | Price 22.52 | Shares 14,914
Buy 6 Mar 2012
Value US$317,996.19 | Price 20.87 | Shares 15,237
Buy 5 Mar 2012
Value US$313,120.35 | Price 20.55 | Shares 15,237
Buy 24 Feb 2012
Value US$54,630.00 | Price 18.21 | Shares 3,000
Buy 15 Dec 2011
Value US$293,019.92 | Price 16.88 | Shares 17,359
Buy 14 Dec 2011
Value US$334,935.20 | Price 16.70 | Shares 20,056
Buy 13 Dec 2011
Value US$1,608,387.00 | Price 17.00 | Shares 94,611
Buy 5 Dec 2011
Value US$50,388.00 | Price 17.68 | Shares 2,850
Buy 5 Dec 2011
Value US$50,036.00 | Price 17.87 | Shares 2,800
Buy 5 Dec 2011
Value US$1,953,219.60 | Price 17.65 | Shares 110,664
Buy 2 Dec 2011
Value US$483,910.00 | Price 17.50 | Shares 27,652
Buy 1 Dec 2011
Value US$440,457.60 | Price 17.60 | Shares 25,026
Buy 25 Nov 2011
Value US$108,832.00 | Price 16.00 | Shares 6,802
Buy 23 Nov 2011
Value US$247,809.16 | Price 16.22 | Shares 15,278
Buy 21 Nov 2011
Value US$193,004.64 | Price 15.48 | Shares 12,468
Buy 18 Nov 2011
Value US$374,928.75 | Price 15.87 | Shares 23,625
Buy 17 Nov 2011
Value US$109,785.00 | Price 16.89 | Shares 6,500
Buy 10 Nov 2011
Value US$212,410.72 | Price 16.48 | Shares 12,889
Buy 9 Nov 2011
Value US$15,398.22 | Price 16.26 | Shares 947
Buy 8 Nov 2011
Value US$4,000,000.00 | Price 16.00 | Shares 250,000
Buy 7 Nov 2011
Value US$112,152.12 | Price 15.69 | Shares 7,148
Buy 4 Nov 2011
Value US$53,279.90 | Price 15.74 | Shares 3,385
Buy 4 Nov 2011
Value US$52,772.04 | Price 14.92 | Shares 3,537
Buy 4 Nov 2011
Value US$91,798.58 | Price 14.78 | Shares 6,211
Buy 9 Sep 2011
Value US$14,950.00 | Price 14.95 | Shares 1,000
Buy 25 May 2011
Value US$3,837,500.00 | Price 15.35 | Shares 250,000
Buy 24 May 2011
Value US$214,691.64 | Price 14.79 | Shares 14,516
Buy 20 May 2011
Value US$6,505,350.00 | Price 13.99 | Shares 465,000
Buy 19 May 2011
Value US$177,897.88 | Price 14.12 | Shares 12,599
Buy 18 May 2011
Value US$182,937.48 | Price 14.52 | Shares 12,599
Buy 11 May 2011
Value US$50,323.68 | Price 15.25 | Shares 3,300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-06-26 2014-06-24 S Sale COVINGTON PAUL S

Senior VP-Clinical Operations

Officer
65,603 +45.3%
110.09
US$2,849,836 		65,603 +45.3% 110.09 US$2,849,836
2014-06-26 2014-06-24 S Sale Patel Sailash

Chief Financial Officer

Officer
74,525 +6.6%
225.25
US$1,920,753 		74,525 +6.6% 225.25 US$1,920,753
2014-06-20 2014-06-18 S Sale COVINGTON PAUL S

Senior VP-Clinical Operations

Officer
26,224 -22.7%
120.09
US$3,069,873 		26,224 -22.7% 120.09 US$3,069,873
2014-06-18 2014-06-17 S Sale McIntyre Gail Frances

Senior Vice President-Research

Officer
8,008 -24.8%
105.00
US$840,840 		8,008 -24.8% 105.00 US$840,840
2014-06-18 2014-06-16 S Sale McIntyre Gail Frances

Senior Vice President-Research

Officer
3,717 -13.3%
105.05
US$390,471 		3,717 -13.3% 105.05 US$390,471
2014-06-18 2014-06-16 S Sale McIntyre Gail Frances

Senior Vice President-Research

Officer
26,000 -51.7%
105.01
US$2,730,260 		26,000 -51.7% 105.01 US$2,730,260
2014-06-18 2014-06-16 S Sale McIntyre Gail Frances

Senior Vice President-Research

Officer
32,928 -57.5%
105.00
US$3,457,440 		32,928 -57.5% 105.00 US$3,457,440
2014-06-18 2014-06-16 S Sale McIntyre Gail Frances

Senior Vice President-Research

Officer
3,804 -13.5%
105.00
US$399,420 		3,804 -13.5% 105.00 US$399,420
2014-06-17 2014-06-13 S Sale COVINGTON PAUL S

Senior VP-Clinical Operations

Officer
3,228 -12.5%
104.25
US$336,519 		3,228 -12.5% 104.25 US$336,519
2014-02-06 2014-02-04 PlS Planned sale Almenoff June Sherie

President

Executive Director
21,718 -46.9%
118.25
US$2,568,154 		21,718 -46.9% 118.25 US$2,568,154
2014-02-06 2014-02-04 PlS Planned sale Almenoff June Sherie

President

Executive Director
93,395 -66.8%
114.60
US$10,703,067 		93,395 -66.8% 114.60 US$10,703,067
2013-09-12 2013-09-10 S Sale COVINGTON PAUL S

Senior VP-Clinical Operations

Officer
30,000 -66.5%
40.89
US$1,226,700 		30,000 -66.5% 40.89 US$1,226,700
2013-08-13 2013-08-09 S Sale CORR PETER B Non-Executive Director
7,500 -67.7%
39.74
US$298,050 		7,500 -67.7% 39.74 US$298,050
2013-07-23 2013-07-19 PlS Planned sale McIntyre Gail Frances

Senior Vice President-Research

Officer
10,581 -37.2%
40.00
US$423,240 		10,581 -37.2% 40.00 US$423,240
2013-07-02 2013-06-28 S Sale CORR PETER B Non-Executive Director
385 -5.6%
34.03
US$13,102 		385 -5.6% 34.03 US$13,102
2013-03-13 2013-03-12 S Sale Kaldor Stephen W Non-Executive Director
973 -37.1%
40.71
US$39,611 		973 -37.1% 40.71 US$39,611
2013-03-13 2013-03-12 S Sale Ruscher Robert P Non-Executive Director
4,262 -37.0%
40.71
US$173,506 		4,262 -37.0% 40.71 US$173,506
2013-03-13 2013-03-11 S Sale Kaldor Stephen W Non-Executive Director
5,379 -67.2%
41.74
US$224,519 		5,379 -67.2% 41.74 US$224,519
2013-03-13 2013-03-11 S Sale Ruscher Robert P Non-Executive Director
23,565 -67.2%
41.74
US$983,603 		23,565 -67.2% 41.74 US$983,603
2012-08-16 2012-08-15 B Purchase Almenoff June Sherie

President

Officer
950 +15.7%
18.68
US$17,746 		950 +15.7% 18.68 US$17,746
2012-08-16 2012-08-14 B Purchase Almenoff June Sherie

President

Officer
50 +0.8%
18.55
US$928 		50 +0.8% 18.55 US$928
2012-06-15 2012-06-14 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
34,133 +1.3%
19.04
US$649,892 		34,133 +1.3% 19.04 US$649,892
2012-06-15 2012-06-13 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
44,193 +1.7%
18.33
US$810,058 		44,193 +1.7% 18.33 US$810,058
2012-06-04 2012-06-01 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
50,319 +2.0%
19.72
US$992,291 		50,319 +2.0% 19.72 US$992,291
2012-06-04 2012-05-31 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
70,075 +2.8%
20.06
US$1,405,704 		70,075 +2.8% 20.06 US$1,405,704
2012-05-31 2012-05-30 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
96,321 +4.1%
19.87
US$1,913,898 		96,321 +4.1% 19.87 US$1,913,898
2012-05-31 2012-05-29 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
72,431 +3.2%
19.96
US$1,445,723 		72,431 +3.2% 19.96 US$1,445,723
2012-05-29 2012-05-25 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
1,454 +0.1%
18.45
US$26,826 		1,454 +0.1% 18.45 US$26,826
2012-05-25 2012-05-24 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
27,000 +1.2%
17.99
US$485,730 		27,000 +1.2% 17.99 US$485,730
2012-05-24 2012-05-23 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
20,000 +0.9%
17.73
US$354,600 		20,000 +0.9% 17.73 US$354,600
2012-05-24 2012-05-22 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
35,000 +1.6%
16.93
US$592,550 		35,000 +1.6% 16.93 US$592,550
2012-05-22 2012-05-21 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
2,400 +0.1%
16.15
US$38,760 		2,400 +0.1% 16.15 US$38,760
2012-05-21 2012-05-18 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
25,000 +1.1%
15.28
US$382,000 		25,000 +1.1% 15.28 US$382,000
2012-05-18 2012-05-17 B Purchase Almenoff June Sherie

President

Officer
2,000 +50.0%
14.80
US$29,600 		2,000 +50.0% 14.80 US$29,600
2012-03-19 2012-03-15 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
7,102 +0.3%
23.91
US$169,809 		7,102 +0.3% 23.91 US$169,809
2012-03-15 2012-03-14 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
22,713 +1.1%
23.75
US$539,434 		22,713 +1.1% 23.75 US$539,434
2012-03-15 2012-03-13 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
22,594 +1.1%
23.45
US$529,829 		22,594 +1.1% 23.45 US$529,829
2012-03-12 2012-03-12 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
22,351 +1.1%
22.69
US$507,144 		22,351 +1.1% 22.69 US$507,144
2012-03-12 2012-03-09 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
15,237 +0.8%
22.59
US$344,204 		15,237 +0.8% 22.59 US$344,204
2012-03-12 2012-03-08 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
14,914 +0.7%
22.52
US$335,863 		14,914 +0.7% 22.52 US$335,863
2012-03-07 2012-03-06 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
15,237 +0.8%
20.87
US$317,996 		15,237 +0.8% 20.87 US$317,996
2012-03-07 2012-03-05 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
15,237 +0.8%
20.55
US$313,120 		15,237 +0.8% 20.55 US$313,120
2012-02-28 2012-02-24 B Purchase Almenoff June Sherie

President

Officer
3,000 +300.0%
18.21
US$54,630 		3,000 +300.0% 18.21 US$54,630
2011-12-19 2011-12-15 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
17,359 +0.9%
16.88
US$293,020 		17,359 +0.9% 16.88 US$293,020
2011-12-15 2011-12-14 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
20,056 +1.0%
16.70
US$334,935 		20,056 +1.0% 16.70 US$334,935
2011-12-15 2011-12-13 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
94,611 +5.1%
17.00
US$1,608,387 		94,611 +5.1% 17.00 US$1,608,387
2011-12-07 2011-12-05 B Purchase COVINGTON PAUL S

Senior VP-Clinical Operations

Officer
2,850 +3904.1%
17.68
US$50,388 		2,850 +3904.1% 17.68 US$50,388
2011-12-07 2011-12-05 B Purchase BONDURANT STUART Non-Executive Director
2,800 +71.9%
17.87
US$50,036 		2,800 +71.9% 17.87 US$50,036
2011-12-05 2011-12-05 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
110,664 +6.4%
17.65
US$1,953,220 		110,664 +6.4% 17.65 US$1,953,220
2011-12-05 2011-12-02 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
27,652 +1.6%
17.50
US$483,910 		27,652 +1.6% 17.50 US$483,910
2011-12-05 2011-12-01 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
25,026 +1.5%
17.60
US$440,458 		25,026 +1.5% 17.60 US$440,458
2011-11-28 2011-11-25 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
6,802 +0.4%
16.00
US$108,832 		6,802 +0.4% 16.00 US$108,832
2011-11-28 2011-11-23 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
15,278 +0.9%
16.22
US$247,809 		15,278 +0.9% 16.22 US$247,809
2011-11-22 2011-11-21 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
12,468 +0.8%
15.48
US$193,005 		12,468 +0.8% 15.48 US$193,005
2011-11-22 2011-11-18 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
23,625 +1.5%
15.87
US$374,929 		23,625 +1.5% 15.87 US$374,929
2011-11-21 2011-11-17 B Purchase McIntyre Gail Frances

Senior Vice President-Research

Officer
6,500 +2425.4%
16.89
US$109,785 		6,500 +2425.4% 16.89 US$109,785
2011-11-14 2011-11-10 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
12,889 +0.8%
16.48
US$212,411 		12,889 +0.8% 16.48 US$212,411
2011-11-10 2011-11-09 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
947 +0.1%
16.26
US$15,398 		947 +0.1% 16.26 US$15,398
2011-11-08 2011-11-08 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
250,000 +18.4%
16.00
US$4,000,000 		250,000 +18.4% 16.00 US$4,000,000
2011-11-08 2011-11-07 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
7,148 +0.5%
15.69
US$112,152 		7,148 +0.5% 15.69 US$112,152
2011-11-08 2011-11-04 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
3,385 +0.3%
15.74
US$53,280 		3,385 +0.3% 15.74 US$53,280
2011-11-08 2011-11-04 B Purchase ESHELMAN FREDRIC N Non-Executive Director Large shareholder
3,537 +0.3%
14.92
US$52,772 		3,537 +0.3% 14.92 US$52,772
2011-11-08 2011-11-04 B Purchase Woodworth Marshall H

Chief Financial Officer

Officer
6,211 +inf%
14.78
US$91,799 		6,211 +inf% 14.78 US$91,799
2011-09-13 2011-09-09 B Purchase Almenoff June Sherie

President

Officer
1,000 +inf%
14.95
US$14,950 		1,000 +inf% 14.95 US$14,950
2011-05-26 2011-05-25 B Purchase ESHELMAN FREDRIC N Non-Executive Director
250,000 +22.8%
15.35
US$3,837,500 		250,000 +22.8% 15.35 US$3,837,500
2011-05-26 2011-05-24 B Purchase ESHELMAN FREDRIC N Non-Executive Director
14,516 +1.3%
14.79
US$214,692 		14,516 +1.3% 14.79 US$214,692
2011-05-20 2011-05-20 B Purchase ESHELMAN FREDRIC N Non-Executive Director
465,000 +75.4%
13.99
US$6,505,350 		465,000 +75.4% 13.99 US$6,505,350
2011-05-20 2011-05-19 B Purchase ESHELMAN FREDRIC N Non-Executive Director
12,599 +2.1%
14.12
US$177,898 		12,599 +2.1% 14.12 US$177,898
2011-05-20 2011-05-18 B Purchase ESHELMAN FREDRIC N Non-Executive Director
12,599 +2.1%
14.52
US$182,937 		12,599 +2.1% 14.52 US$182,937
2011-05-12 2011-05-11 B Purchase BONDURANT STUART Non-Executive Director
3,300 +553.7%
15.25
US$50,324 		3,300 +553.7% 15.25 US$50,324
Explore more

More insider trading research around Furiex Pharmaceuticals LLC

More insider trades in United States
Insider trading in North America